Alkali Metals Ltd
Incorporated in 1968, Alkali Metals Ltd is a manufacturer of Sodium Derivatives, Pyridine Derivatives, Fine Chemicals and APIs etc.[1]
- Market Cap ₹ 90.8 Cr.
- Current Price ₹ 89.4
- High / Low ₹ 127 / 74.0
- Stock P/E
- Book Value ₹ 43.7
- Dividend Yield 0.56 %
- ROCE -4.87 %
- ROE -7.28 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 50.4%
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.05% over past five years.
- Company has a low return on equity of 0.60% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 66.04 | 68.44 | 73.28 | 61.12 | 64.93 | 71.56 | 70.85 | 55.38 | 91.02 | 88.23 | 82.86 | 82.33 | 88.28 | |
| 62.64 | 59.01 | 63.35 | 54.28 | 58.13 | 64.14 | 64.17 | 49.32 | 79.64 | 78.55 | 74.57 | 83.07 | 85.74 | |
| Operating Profit | 3.40 | 9.43 | 9.93 | 6.84 | 6.80 | 7.42 | 6.68 | 6.06 | 11.38 | 9.68 | 8.29 | -0.74 | 2.54 | 
| OPM % | 5.15% | 13.78% | 13.55% | 11.19% | 10.47% | 10.37% | 9.43% | 10.94% | 12.50% | 10.97% | 10.00% | -0.90% | 2.88% | 
| 0.44 | -0.35 | 0.25 | 0.12 | 0.50 | 0.40 | 0.35 | 0.05 | 0.14 | 1.05 | 0.42 | -0.75 | -0.79 | |
| Interest | 3.49 | 4.50 | 3.44 | 2.96 | 2.52 | 2.71 | 2.47 | 2.54 | 2.63 | 2.67 | 2.56 | 2.40 | 2.26 | 
| Depreciation | 3.52 | 4.27 | 3.75 | 3.62 | 3.48 | 3.41 | 3.45 | 3.35 | 3.86 | 4.29 | 4.60 | 4.15 | 3.88 | 
| Profit before tax | -3.17 | 0.31 | 2.99 | 0.38 | 1.30 | 1.70 | 1.11 | 0.22 | 5.03 | 3.77 | 1.55 | -8.04 | -4.39 | 
| Tax % | -38.17% | 6.45% | 24.41% | 7.89% | 0.00% | 0.00% | -12.61% | 650.00% | 30.82% | 22.55% | 27.10% | -27.86% | |
| -1.96 | 0.28 | 2.26 | 0.35 | 1.31 | 1.69 | 1.25 | -1.21 | 3.48 | 2.91 | 1.13 | -5.80 | -3.63 | |
| EPS in Rs | -1.92 | 0.27 | 2.22 | 0.34 | 1.29 | 1.66 | 1.23 | -1.19 | 3.42 | 2.86 | 1.11 | -5.70 | -3.57 | 
| Dividend Payout % | 0.00% | 0.00% | 54.05% | 145.43% | 77.71% | 72.28% | 81.44% | -67.31% | 58.51% | 69.97% | 90.09% | -8.78% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% | 
| 5 Years: | 3% | 
| 3 Years: | -3% | 
| TTM: | 10% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % | 
| 5 Years: | % | 
| 3 Years: | % | 
| TTM: | 31% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% | 
| 5 Years: | 13% | 
| 3 Years: | -13% | 
| 1 Year: | -23% | 
| Return on Equity | |
|---|---|
| 10 Years: | 2% | 
| 5 Years: | 1% | 
| 3 Years: | 1% | 
| Last Year: | -7% | 
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 10.18 | 
| Reserves | 40.55 | 39.19 | 39.97 | 40.34 | 41.20 | 41.85 | 40.10 | 39.19 | 41.90 | 42.68 | 41.16 | 34.34 | 
| 35.87 | 32.75 | 21.69 | 21.44 | 18.08 | 18.19 | 19.99 | 21.92 | 17.25 | 23.82 | 22.84 | 18.18 | |
| 14.75 | 12.47 | 15.14 | 17.55 | 19.46 | 20.81 | 16.98 | 24.96 | 27.42 | 25.24 | 31.33 | 28.39 | |
| Total Liabilities | 101.35 | 94.59 | 86.98 | 89.51 | 88.92 | 91.03 | 87.25 | 96.25 | 96.75 | 101.92 | 105.51 | 91.09 | 
| 61.06 | 57.00 | 53.71 | 49.84 | 46.82 | 44.76 | 44.87 | 46.66 | 46.27 | 49.47 | 47.29 | 41.03 | |
| CWIP | 0.00 | 0.36 | 0.46 | 1.56 | 1.55 | 2.12 | 2.15 | 0.43 | 0.63 | 1.33 | 0.19 | 0.00 | 
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| 40.29 | 37.23 | 32.81 | 38.11 | 40.55 | 44.15 | 40.23 | 49.16 | 49.85 | 51.12 | 58.03 | 50.06 | |
| Total Assets | 101.35 | 94.59 | 86.98 | 89.51 | 88.92 | 91.03 | 87.25 | 96.25 | 96.75 | 101.92 | 105.51 | 91.09 | 
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.18 | 9.16 | 8.28 | 4.19 | 4.50 | 6.90 | 9.43 | 1.32 | 11.19 | 11.19 | 6.29 | 5.44 | |
| -3.08 | -2.11 | -0.44 | -0.97 | -0.41 | -2.81 | -3.74 | -3.52 | -2.84 | -3.14 | -1.64 | -0.75 | |
| 2.27 | -5.53 | -9.92 | -3.26 | -4.06 | -4.08 | -3.16 | 0.07 | -6.82 | -8.96 | -5.71 | -4.69 | |
| Net Cash Flow | 0.37 | 1.52 | -2.08 | -0.05 | 0.03 | 0.02 | 2.53 | -2.13 | 1.53 | -0.91 | -1.06 | 0.00 | 
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74.72 | 45.65 | 56.28 | 61.39 | 79.26 | 54.78 | 32.82 | 79.02 | 53.74 | 56.63 | 79.16 | 63.57 | 
| Inventory Days | 139.35 | 176.18 | 119.11 | 251.90 | 194.18 | 241.56 | 233.58 | 493.80 | 245.90 | 277.93 | 381.69 | 223.28 | 
| Days Payable | 134.00 | 111.92 | 116.85 | 182.90 | 166.75 | 169.77 | 121.63 | 318.70 | 165.04 | 180.30 | 281.00 | 161.04 | 
| Cash Conversion Cycle | 80.07 | 109.91 | 58.55 | 130.39 | 106.70 | 126.57 | 144.76 | 254.13 | 134.59 | 154.26 | 179.84 | 125.82 | 
| Working Capital Days | 6.02 | -13.01 | -24.01 | -9.50 | 7.65 | 14.69 | 5.31 | 48.57 | 25.91 | 20.52 | 31.50 | 1.37 | 
| ROCE % | 0.36% | 6.97% | 8.35% | 5.05% | 5.47% | 6.31% | 5.41% | 4.10% | 11.11% | 8.94% | 5.99% | -4.87% | 
Documents
Announcements
- 
        
          Board Meeting Intimation for Approval Of Unaudited Results
          
            23h - Board meeting on 7 Nov 2025 to approve Q2 and H1 un-audited results for period ended 30 Sep 2025.
- 
        
          Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
          
            18 Oct - Confirmation under Regulation 74(5) for quarter ended 30 Sep 2025; dematerialisation certificates accepted/cancelled.
- Closure of Trading Window 30 Sep
- 
        
          Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
          
            22 Aug - Members approved M/s. J V S L & Associates as statutory auditors for five years (2025–2030) at 57th AGM.
- Update On The 57Th AGM 21 Aug
Annual reports
- 
    
      Financial Year 2025
      from bse
- 
    
      Financial Year 2024
      from bse
- 
    
      Financial Year 2023
      from bse
- 
    
      Financial Year 2022
      from bse
- 
    
      Financial Year 2021
      from bse
- 
    
      Financial Year 2020
      from bse
- 
    
      Financial Year 2019
      from bse
- 
    
      Financial Year 2018
      from bse
- 
    
      Financial Year 2017
      from bse
- 
    
      Financial Year 2016
      from bse
- 
    
      Financial Year 2015
      from bse
- 
    
      Financial Year 2014
      from bse
- 
    
      Financial Year 2013
      from bse
- 
    
      Financial Year 2013
      from nse
- 
    
      Financial Year 2012
      from bse
Business Overview:[1]
AML, originally a joint venture with Andhra Pradesh Industrial Development Corporation Limited (APIDCL), is now an ISO 9001 & 14001-certified manufacturer specializing in sodium metal derivatives, picoline-based compounds, and cyclic chemicals. Its key products include sodium amide, sodium azide, sodium hydride, amino pyridines, fine chemicals, and APIs, primarily supplied to pharmaceutical companies for bulk drug production